Cargando…
The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model
BACKGROUND: Cancer metastasis contributes significantly to cancer mortality and is facilitated by lymphangiogenesis and angiogenesis. A new splicing variant, endogenous soluble vascular endothelial growth factor receptor-2 (esVEGFR-2) that we recently identified is an endogenous selective inhibitor...
Autores principales: | Shibata, Masa-Aki, Ambati, Jayakrishna, Shibata, Eiko, Albuquerque, Romulo JC, Morimoto, Junji, Ito, Yuko, Otsuki, Yoshinori |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989928/ https://www.ncbi.nlm.nih.gov/pubmed/21047425 http://dx.doi.org/10.1186/1741-7015-8-69 |
Ejemplares similares
-
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models
por: Ito, Yuko, et al.
Publicado: (2011) -
Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer
por: Shibata, Masa-Aki, et al.
Publicado: (2010) -
α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation
por: Shibata, Masa-Aki, et al.
Publicado: (2011) -
Soluble Vegfr3 gene therapy suppresses multi‐organ metastasis in a mouse mammary cancer model
por: Shibata, Masa‐Aki, et al.
Publicado: (2020) -
Synthetic α‐mangostin dilaurate strongly suppresses wide‐spectrum organ metastasis in a mouse model of mammary cancer
por: Shibata, Masa‐Aki, et al.
Publicado: (2018)